Partnerships and Alliances
Murdoch University
The Institute has always had a close relationship with Murdoch University through Professor Howell and the School of Veterinary and biomedical Sciences. Professor Howell and other members of the Gene Therapy Research Group have investigated possible treatments for Duchenne Muscular Dystrophy using a colony of dystrophin deficient dogs which were kept at Murdoch University. They are currently investigating possible treatments for another inherited disease of human muscle called McArdle\\\\\\\'s disease. In order to do this they are using the only flock of sheep in the world with this glycogen storage disease. This work, part of the ANRI research programme, is being done at Murdoch University.
Phylogica
Over the last 3 years the Stroke Research Group have been involved in two research projects with the Biotech company, Phylogica Pty Ltd. An Ausindustry funded Biotechnology Innovative Fund grant and more recently a State Government Neurotrauma Research Program grant have been obtained in collaboration with Phylogica in order to perform pre-clinical trials of their c-Jun inhibitory peptides for stroke treatment.
The West Australian Institute of Medical Research (WAIMR)
Neurotrauma Research Grants are supported by The State Government (Administered through WAIMR) supports research into brain and spinal injuries caused by traffic accidents.
Alzheimer's Centre of Excellence
Over the past 3 years we have been collaborating with Professor Ralph Martins and the Alzheimer’s Disease Centre of Excellence on projects such as the investigation into the natural history of mild cognitive impairment.
The University of Western Australia
The Institute has always enjoyed a strong relationship with The University of Western Australia, initially through a formal a liation agreement, then with the establishment of the Centre for Neuromuscular and Neurological Disorders (CNND).
Sir Charles Gairdner Hospital
The Institute is located on the Sir Charles Gairdner Hospital site and is supported by SCGH infrastructure. SCGH generously provide small grants and scholarships.
GlaxoSmithKline
A high though-put genotyping facility has been in operation at the Institute since November 1999. Established as a collaborative initiative with GlaxoSmithKline as part of their pharmacogenetics program, this facility started carrying out genome wide scans using microsatellite markers on families recruited from around the world by GSK. During 2006 the Molecular Research Unit was set up to provide a broad range of gene screening and genotyping services to research groups both within and outside the Institute. The Unit uses state-of-the-art equipment and facilities, provided through a collaboration with GlaxoSmithKline.
Allergan Australia
I would again like to acknowledge the generous support of Allergan Australia in providing funds for a Movement Disorders Fellowship and for much needed laboratory equipment.
Pfizer Australia
Generous support is provided by P zer by way of a Neuroscience Research Grant for research into treatments for Parkinson’s disease using transcranial brain stimulation.
Royal Perth Hospital
Clinics, consultancies, teaching, diagnostics and collaborations are on going with many departments and staff at RPH including Professor Frank Christiansen, A/Professor Phillipa Lamont and Drs Fabiana and Davis.
Curtin University
The Institute continues to supervise Honours and PhD Students enrolled through Curtin. Undertake teaching and collaborate with eminent researchers such as Professor Michael Garlepp and Professor John Mamo.
Edith Cowan University
The Institute continues to supervise Honours and PhD Students from ECU.
Princess Margaret’s Hospital for Children
Over the last 4 years, the movement research group has been collaborating with Dr Lakshmi Nagarajan in the Department of Neurology, Princess Margaret’s Hospital.
Channel 7 Telethon
Funding from Channel 7s Telethon enabled a new group Molecular Neurobiology to be set up, and research into inherited childhood diseases to be undertaken.